Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2018 pubmed 47 citations

Host Defense Peptide LL-37-Mediated Chemoattractant Properties, but Not Anti-Inflammatory Cytokine IL-1RA Production, Is Selectively Controlled by Cdc42 Rho GTPase <i>via</i> G Protein-Coupled Receptors and JNK Mitogen-Activated Protein Kinase.

Hemshekhar. Mahadevappa M; Choi. Ka-Yee Grace KG; Mookherjee. Neeloffer N

Key Findings

  • LL-37 triggers production of chemokines (GRO-α, IL-8) and recruitment of monocytes and neutrophils through Cdc42/Rac1 GTPases.
  • The anti‑inflammatory cytokine IL-1RA induced by LL-37 is independent of Cdc42/Rac1 and Ras pathways.
  • Cdc42/Rac1 signals via GPCRs and the JNK MAPK pathway, not via p38 or ERK MAPKs, to mediate LL-37’s chemoattractant effects.

Practical Outcomes

  • For self‑experimenters, the work suggests that if you want to boost LL-37’s immune‑recruiting actions, you might need to support Cdc42 activity (e.g., via compounds that activate this GTPase). Conversely, LL-37’s anti‑inflammatory benefits appear to work without Cdc42, so targeting Cdc42 won’t diminish those effects. However, the study is purely mechanistic and does not provide dosage or direct protocol guidance.

Summary

The study shows that the human peptide LL-37 can pull immune cells to a site (chemoattractant) by turning on a protein called Cdc42, but its ability to calm inflammation (by making IL-1RA) does not need Cdc42. In other words, Cdc42 acts like a switch that decides whether LL-37 acts like a rally‑call for immune cells or like a peace‑keeper.

Abstract

The human host defense peptide LL-37 promotes immune activation such as induction of chemokine production and recruitment of leukocytes. Conversely, LL-37 also mediates anti-inflammatory responses such as production of anti-inflammatory cytokines, e.g., IL-1RA, and the control of pro-inflammatory cytokines, e.g., TNF. The mechanisms regulating these disparate immunomodulatory functions of LL-37 are not completely understood. Rho GTPases are GTP-binding proteins that promote fundamental immune functions such as chemokine production and recruitment of leukocytes. However, recent studies have shown that distinct Rho proteins can both negatively and positively regulate inflammation. Therefore, we interrogated the role of Rho GTPases in LL-37-mediated immunomodulation. We demonstrate that LL-37-induced production of chemokines, e.g., GRO-&#x3b1; and IL-8 is largely dependent on Cdc42/Rac1 Rho GTPase, but independent of the Ras pathway. In contrast, LL-37-induced production of the anti-inflammatory cytokine IL-1RA is not dependent on either Cdc42/Rac1 RhoGTPase or Ras GTPase. Functional studies confirmed that LL-37-induced recruitment of leukocytes (monocytes and neutrophils) is also dependent on Cdc42/Rac1 RhoGTPase activity. We demonstrate that Cdc42/Rac1-dependent bioactivity of LL-37 involves G-protein-coupled receptors (GPCR) and JNK mitogen-activated protein kinase (MAPK) signaling, but not p38 or ERK MAPK signaling. We further show that LL-37 specifically enhances the activity of Cdc42 Rho GTPase, and that the knockdown of Cdc42 suppresses LL-37-induced production of chemokines without altering the peptide's ability to induce IL-1RA. This is the first study to demonstrate the role of Rho GTPases in LL-37-mediated responses. We demonstrate that LL-37 facilitates chemokine production and leukocyte recruitment engaging Cdc42/Rac1 Rho GTPase <i>via</i> GPCR and the JNK MAPK pathway. In contrast, LL-37-mediated anti-inflammatory cytokine IL-1RA production is independent of either Rho or Ras GTPase. The results of this study suggest that Cdc42 Rho GTPase may be the molecular switch that controls the opposing functions of LL-37 in the process of inflammation.

Study Information

Provider

pubmed

Year

2018

Date

2018-08-13T00:00:00.000Z

DOI

10.3389/fimmu.2018.01871

Citations

47

References

64